Cardiovascular Prevention and Pharmacotherapy

All of the manuscripts should be prepared based on strict observation of research and publication ethics guidelines recommended by the Council of Science Editors (http://www.councilscienceeditors.org), International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org), World Association of Medical Editors (WAME, http://www.wame.org), and the Korean Association of Medical Journal Editors (KAMJE, https://www.kamje.or.kr/en/main_en). Any studies involving human subject must comply with the principles of the World Medical Association Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects).

Clinical research should be approved by the Institutional Review Board, as well through patient consent. A patient’s personal information cannot be published in any form. However, if it is absolutely necessary to use a patient’s personal information, the consent of the patient or his/her guardian will be needed before publishing. Animal studies should be performed in compliance with all relevant guidelines, observing the standards described in the NIH Guide for the Care and Use of Laboratory Animals. (http://www.nap.edu/readingroom/books/labrats/index.html). Research investigators should obey the regulations of ethics committee of corresponding institutes. The editors of Cardiovascular Prevention and Pharmacotherapy could demand informed consent and permission of ethics committee of corresponding institute. The journal will follow the guidelines by the Committee on Publication Ethics (COPE, http://publicationethics.org) for settlement of any misconduct.

Research and publication ethics